Correlation Between Neurocrine Biosciences and BHCCN

Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and BHCCN at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and BHCCN into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neurocrine Biosciences and BHCCN 14 15 OCT 30, you can compare the effects of market volatilities on Neurocrine Biosciences and BHCCN and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of BHCCN. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and BHCCN.

Diversification Opportunities for Neurocrine Biosciences and BHCCN

0.05

Correlation Coefficient

Neurocrine Biosciences  BHCCN

Significant diversification

The 3 months correlation between Neurocrine and BHCCN is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and BHCCN 14 15 OCT 30 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BHCCN 14 15 and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with BHCCN. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BHCCN 14 15 has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and BHCCN go up and down completely randomly.

Pair Corralation between Neurocrine Biosciences and BHCCN

Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 0.37 times more return on investment than BHCCN. However, Neurocrine Biosciences is 2.7 times less risky than BHCCN. It trades about -0.1 of its potential returns per unit of risk. BHCCN 14 15 OCT 30 is currently generating about -0.13 per unit of risk. If you would invest  13,706  in Neurocrine Biosciences on December 29, 2024 and sell it today you would lose (2,390) from holding Neurocrine Biosciences or give up 17.44% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	67.21%
Values	Daily Returns

Neurocrine Biosciences  vs.  BHCCN 14 15 OCT 30

Neurocrine Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Neurocrine Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

BHCCN 14 15

Risk-Adjusted Performance

Very Weak

Over the last 90 days BHCCN 14 15 OCT 30 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Bond's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for BHCCN 14 15 OCT 30 investors.

Pair Trading with Neurocrine Biosciences and BHCCN

The main advantage of trading using opposite Neurocrine Biosciences and BHCCN positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, BHCCN can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BHCCN will offset losses from the drop in BHCCN's long position.

The idea behind Neurocrine Biosciences and BHCCN 14 15 OCT 30 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.